Acusphere raises $15 million

Pharmaceutical firm Acusphere has received $15 million in a round of private equity financing led by Thomas Weisel Capital Partners. Watertown, MA-based Acusphere said it would use the financing to support ongoing clinical development of its three product candidates, including its AI-700 ultrasound contrast agent for the detection of coronary artery disease.

By AuntMinnie.com staff writers
July 24, 2002

Related Reading

Acusphere US contrast agent research presented at ASE, July 19, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 512
Next Page